Krka, d. d., Novo mesto (hereinafter Krka) announces to the interested public that an out-of-court settlement in the donepezil case has been reached.

On 24 February 2010 Krka and Krka Sverige AB, as defendants, and Eisai Co., Ltd. and Pfizer AS, as plaintiffs, agreed the out-of-court settlement of the patent dispute before the Oslo District Court concerning Donepezil Krka.

Under the terms of the settlement Krka receives payment of EUR 1.55 million from Eisai Co., Ltd. and continues to market donepezil in Norway.

Krka published the information about the temporary injunction issued against Krka Sverige for the alleged infringement of the manufacturing patent for donepezil tablets in Norway on 19 November 2008 and about the invalidation of the injunction on 13 March 2009.